Xconomy Forum:
What's Hot in Boston Biotech

 

Save $150 with our special MassBio rate

 

It's no secret that biotech is feeling it once again. Stocks are way up, and startups are seizing the opportunity to sail through a wide-open IPO window. That bull market isn’t just generating big returns for investors, it’s helping fuel the next round of innovation. Ambitious startups are sprouting up, sparked by science that is turning heads. New, nontraditional sources of cash are turning their attention to life sciences, creating unlikely options for fledgling biotechs that simply weren’t imagined a short time ago. But which ideas are generating the most buzz? What’s it going to take for the grandiose visions to become reality? And what does it all mean for drug discovery and health? Join Xconomy as we bring together some of the Boston biotech scene’s top innovators, venture capitalists, and executives, who are at the forefront of some of the biggest new ideas in life sciences.

Confirmed speakers:
Michael Bonney, CEO, Cubist Pharmaceuticals
Douglas Williams, EVP, Research and Development, Biogen Idec
John Maraganore, CEO, Alnylam Pharmaceuticals
David Berry, CEO, Seres Health; Partner, Flagship Ventures
Kevin Bitterman, Interim CEO, Editas Medicine; Principal, Polaris Partners
Katrine Bosley, Entrepreneur-in-residence, Broad Institute
Steven Holtzman, EVP, Corporate Development, Biogen Idec
Andrew Lo, Professor of Finance, MIT
Nancy Simonian, CEO, Syros Pharmaceuticals
Feng Zhang, Professor of Biomedical Engineering, MIT

Schedule:
Registration: 12:30 – 1:30 pm
Program:  1:30 – 5:30 pm
Networking Reception: 5:30 – 6:30 pm

Location:
Biogen Idec - Building 8
15 Cambridge Center
Cambridge, MA 02142

Twitter:
@Xconomy
#xconBio

Registration information:
Special rate for MassBio: $175
Regular Registration: $325
Student: $50
At the Door: $375
Tickets are transferable but not refundable.
To inquire about press registration, e-mail events@xconomy.com.